Anixa Biosciences, Inc. Share Price

Anixa Biosciences, Inc. Share Price

NASDAQ: ANIX | Micro Cap
$3.33
-$0.04 (-1.04%) Last updated on 29 Oct, 2026 | 20:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Anixa Biosciences, Inc. Stock Performance

Open
$3.40
Prev. Close
$3.37
Circuit Range
N/A
Day Range
$3.29 - $3.40
Year Range
$2.37 - $5.43
Volume
2,665
Average Traded
$3.34

Anixa Biosciences, Inc. Share Price Today

As of 29 October 2026, Anixa Biosciences, Inc.'s share price is $3.33. The stock opened at $3.40, compared to its previous close of $3.37. During today's trading session, Anixa Biosciences, Inc.'s share price traded between $3.29 and $3.40, with an average price of $3.34. Over the past 52 weeks, the stock has recorded a high of $5.43 and a low of $2.37. In terms of performance, Anixa Biosciences, Inc.'s share price has risen by 12.86% over the last six months and is down 19.25% on a year-on-year basis.

Anixa Biosciences, Inc. Share Price Chart

Line chart of the Anixa Biosciences, Inc. price trend over the selected period. The price fell overall, ranging from 3.29 to 3.40, ending at 3.33.
$3.29$3.40
L
Show Current Price
H

Anixa Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$108234.09
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.30
Revenue (TTM)
$0.00
Return On Equity (TTM)
-71.74%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
3.33%

Anixa Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.70-$2.57-$2.52-$2.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.81%1.95%-3.57%

Anixa Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.21$0.00$0.00
Net Profit-$13.60-$9.81-$12.55-$10.93
Net Profit MarginN/A-4671.43%N/AN/A
Income ChangeN/A27.87%-27.93%12.91%

About Anixa Biosciences, Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Anixa Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.90
$3.33
+14.04%
Sep 2026
$3.33
$2.92
-19.11%
Aug 2026
$3.45
$3.61
+4.79%
Jul 2026
$2.81
$3.44
+21.52%
Jun 2026
$2.70
$2.83
+3.85%
May 2026
$2.99
$2.73
-7.61%
Apr 2026
$2.76
$2.96
+13.22%
Mar 2026
$2.94
$2.61
-12.12%
Feb 2026
$3.02
$2.97
-2.14%
Jan 2026
$3.17
$3.04
-1.46%
Dec 2025
$4.54
$3.08
-32.82%
Nov 2025
$4.00
$4.58
+11.02%

ANIX Share Price FAQs